NEOGRAFT

NEOGRAFT Technologies is a medical device company dedicated to developing technical equipment for coronary artery bypass surgery. Established in 2009, the company is headquartered on the East Coast of the United States. NEOGRAFT Technologies' flagship product is Angioshield, a device used to deliver controlled temporary structural support to veins utilized as arteriovenous grafts. This product can be applied in vascular reconstruction for both coronary and peripheral arteries.